Table 2.
Variable | CS (n=68) | PV (n=163) | CS‐A (n=68) | |||
---|---|---|---|---|---|---|
R | P value | R | P value | R | P value | |
Coronary hemodynamics | ||||||
Coronary flow reserve | −0.24 | <0.05* | −0.23 | <0.01* | −0.13 | 0.30 |
Index of microcirculatory resistance | 0.09 | 0.50 | 0.03 | 0.72 | −0.14 | 0.26 |
Post‐PPCI cardiac MRI | ||||||
Ejection fraction | −0.18 | 0.22 | −0.26 | 0.01* | −0.06 | 0.66 |
Microvascular obstruction | 0.49 | <0.001* | 0.09 | 0.42 | −0.14 | 0.35 |
Edema (% LV) | 0.49 | <0.001* | 0.25 | 0.02* | −0.03 | 0.82 |
Late gadolinium enhancement | 0.36 | 0.01* | 0.07 | 0.52 | −0.12 | 0.41 |
End‐diastolic volume | 0.12 | 0.42 | 0.12 | 0.23 | 0.09 | 0.53 |
End‐systolic volume | 0.15 | 0.35 | 0.20 | 0.05* | 0.18 | 0.28 |
6‐mo Cardiac MRI | ||||||
Ejection fraction | −0.43 | 0.01* | −0.26 | 0.02* | 0.29 | 0.08 |
End‐diastolic volume | 0.08 | 0.61 | 0.09 | 0.43 | −0.07 | 0.69 |
End‐systolic volume | 0.23 | 0.16 | 0.23 | 0.03* | −0.19 | 0.25 |
Late gadolinium enhancement | 0.57 | <0.001* | 0.27 | 0.01* | −0.11 | 0.52 |
CS indicates coronary sinus; LV, left ventricle; MRI, magnetic resonance imaging; NPY, neuropeptide Y; PPCI, primary percutaneous coronary intervention; and PV, peripheral venous.
indicates statistical significance.